Literature DB >> 31157890

Ways to use interventions to increase participation in mail-out bowel cancer screening: a systematic review and meta-analysis.

Larry Myers1, Belinda Goodwin2, Sonja March1,2, Jeff Dunn2,3,4,5.   

Abstract

The impact of colorectal cancer can be reduced through nationwide fecal occult blood test (FOBT) screening. Unfortunately, participation in screening programs are low with interventions only increasing participation modestly. This meta-analysis explores if intervention effectiveness can be increased by targeting specific subpopulations with specific interventions or by combining interventions. Six databases were searched for studies aiming to increase participation in mail-out FOBT screening. To investigate if interventions are more effective for certain subpopulations, the difference in (log) Risk Ratios (RRs) between alternate subpopulations (male vs. female; low vs. high Socioeconomic Status (SES); <65 vs. ≥65 years) was assessed. To investigate if interventions should be combined, uptake rates for single interventions were compared to uptake rates for combined interventions. Cochrane Collaboration tools were used to assess the risk of bias. Searches found 3,436 articles, with 32 meeting the inclusion criteria. These contained 30 trials that reported uptake rates within subpopulations and 17 trials that combined interventions. Most differences in intervention effects between subpopulations were nonsignificant. Combining interventions led to greater participation, RR = 1.06, confidence interval [1.03; 1.10]. As interventions rarely affect subpopulations differently, targeting them at specific subpopulations may be an ineffective strategy. While individual interventions show modest effects, these results indicate that future programs might overcome this by combining interventions together. Care is needed when selecting interventions to combine as adding some interventions (e.g., additional print materials) can reduce the effectiveness of a combined strategy. Future research should examine methods for effectively combining interventions in nationwide programs to maximize participation. © Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Colorectal cancer; Fecal occult blood test; Population screening; Systematic review

Mesh:

Year:  2020        PMID: 31157890     DOI: 10.1093/tbm/ibz081

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  4 in total

1.  The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.

Authors:  Anna Wood; Jon D Emery; Mark Jenkins; Patty Chondros; Tina Campbell; Edweana Wenkart; Clare O'Reilly; Tony Cowie; Ian Dixon; Julie Toner; Hourieh Khalajzadeh; Javiera Martinez Gutierrez; Linda Govan; Gemma Buckle; Jennifer G McIntosh
Journal:  Trials       Date:  2022-01-12       Impact factor: 2.279

2.  The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review.

Authors:  Désirée Schliemann; Kogila Ramanathan; Nicholas Matovu; Ciaran O'Neill; Frank Kee; Tin Tin Su; Michael Donnelly
Journal:  BMC Cancer       Date:  2021-10-19       Impact factor: 4.430

Review 3.  The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials.

Authors:  Laura F Gruner; Efrat L Amitay; Thomas Heisser; Feng Guo; Tobias Niedermaier; Anton Gies; Michael Hoffmeister; Hermann Brenner
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639

4.  A health action process approach for developing invitee endorsed interventions to increase mail-out bowel cancer screening.

Authors:  Larry Myers; Belinda Goodwin; Nicholas Ralph; Sonja March
Journal:  Appl Psychol Health Well Being       Date:  2022-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.